伴TP53基因异常骨髓增生异常综合征患者的临床特征及预后研究

OBJECTIVE: To explore the clinical implications and prognostic value of TP53 gene mutation and deletion in patients with myelodysplastic syndromes (MDS). METHODS: 112-gene targeted sequencing and interphase fluorescence in situ hybridization (FISH) were used to detect TP53 mutation and deletion in 5...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial office of Chinese Journal of Hematology 2019
Materias:
论著
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342541/
https://www.ncbi.nlm.nih.gov/pubmed/30929389
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7342541/
https://www.ncbi.nlm.nih.gov/pubmed/30929389
http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2019.03.010

Ejemplares similares